BioBoard

Australia
•  World's Biggest Genebank on Its Way in Australia
•  Australian Researchers Discover New Improved Hepatitis C Model
•  Meat and Livestock Australia Invests $1 million for New Livestock Pathogen Research Project
•  Australia's Cloning Stance 'Damaging' to International Research
•  Locust Researcher Dr Richard Milner Named Finalist for Eureka Prize
•  11th International Congress of Human Genetics Held in Brisbane

China
•  Eiken to Launch New Subsidiary and Factory in China
•  Ginseng May Improve Breast Cancer Outcomes
•  China Claims Successful Phase I Trial of AIDS Vaccine

India
•  Merck to Focus on India for Clinical Trials
•  Avra Labs to Invest in New Facility
•  India and US Pharmacopeia Sign MoU to Promote Awareness About Medicines
•  India's Use of GM Cotton to Double in 2007
•  Orchid Gets FDA Approval for Cefotaxime Injections
•  India Claims It is 'Avian Influenza-Free Country'
•  Viread to Retail for $1 in India
•  Indian Government Sets up Committee on GM Food

Indonesia
•  Indonesia Opens up Access to Bird Flu Gene Codes

Japan
•  NIAS and Sanger Institute Conclude Agreement on Pig Genome Research
•  GlaxoSmithKline and Shionogi Complete HIV Drug Study

Korea
•  Singapore's Raffles Medical Group to Expand into South Korea

Malaysia
•  Malaysia's Call to Venture into Nanobiotechnology

Singapore
•  Eisai Pharmaceutical Marketing Subsidiary in Singapore Launches Operations
•  IFPMA Organizes the Asian Regional Conference on Intellectual Property, Innovation and Health
•  Former NNI Director's Breach of Ethical Conduct
•  Dr John Brown Joins SingVax as Chairman
•  Merck Invests S$100 million for Expansion in Singapore

Taiwan
•  NSC Considering Plans for Clinical Research Facility

Thailand
•  GSK Withdraws Application for AIDS Drugs in Thailand and India
•  Thailand's HIV/AIDS Treatment Should Serve as a Model for Other Countries

Special Feature
•  Drug Discovery in China
•  Pharmaceutical Industrial Partnering Trends in India

Industry Watch
•  Tissue Therapies Limited Announced the Creation of a Fundamentally New Molecule
•  Novozymes Bid for Australian Biotech Company GroPep Ltd.
•  NeuroDiscovery, Entered an Agreement with King's College London
•  Benitec and CSIRO Continues to Collaborate
•  Phynova to Buy 45% of China's Botanic Century
•  Aida Pharmaceuticals Acquires 77.5% of Chinese Gene Drug Pioneer -- Shanghai Qiaer Bio-Technology
•  Gilead Collaborates with Three Indian Companies for Generic Versions of Viread in the Developing World
•  Ranbaxy Buys Russian Generic Drugs Maker Akrikhin for $110 million
•  ShinNippon Agrees Licensing Nasal Drug Delivery Technology to Tokai Pharmaceuticals
•  Schering-Plough Withdraws Application for Antibiotic Filing
•  Japan Biovntures Today -- Oncolys BioPharma Inc
•  MerLion Pharmaceuticals Merges with Two European Companies

Commentaries & Analysis
•  Review of China's Biopharmaceautical Industries in Recent Years

People Profile
•  Frontiers of Leukemia Research -- Dr Ching Hon Pui

Conference Calendar